Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor

被引：0
|
作者：
Sayaka Misaki
Satoshi Murata
Miyuki Shimoji
Takayasu Iwai
Andreas Michael Sihombing
Ken Aoki
Yutaka Takahashi
Yoshiyuki Watanabe
机构：
[1] Shiga University of Medical Science,Department of Radiology
[2] Shiga University of Medical Science Hospital,Cancer Center
[3] Shiga University of Medical Science,Department of Surgery
[4] Osaka University Graduate School of Medicine,Department of Medical Physics and Engineering
来源：
Japanese Journal of Radiology | 2022年 / 40卷
关键词：
Radioimmunotherapy; Tumor antigen-specific CD8-positive T-lymphocyte; Cytotoxic T-lymphocyte; Immune checkpoint inhibitor; Abscopal effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1307 / 1315
页数：8
相关论文
共 50 条
  • [41] Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers
    Wang, Yingnan
    Zhang, Shasha
    Zhang, Fengbin
    Wang, Lei
    Wu, Chensi
    Zhang, Xiaoyun
    Zhang, Ruixing
    Guo, Zhanjun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Characterization of the immune checkpoint inhibitor response in the MC38 murine colon cancer model
    Fadden, Patrick
    Bui, Thi
    Hurtado, David
    Davis, Kelli
    Belle, Ian
    Krontz, Kathrine
    Hauser, Jacob
    Li, Na
    Takayama, Kyle
    Sokolowski, Cristina
    Wood, Edgar
    CANCER RESEARCH, 2019, 79 (13)
  • [43] Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer
    Wu, Xueying
    Zhang, Chenyang
    Zhang, Henghui
    CURRENT ONCOLOGY, 2022, 29 (01) : 283 - 293
  • [44] Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
    Pizzamiglio, Sara
    Ciniselli, Chiara Maura
    Triulzi, Tiziana
    Gargiuli, Chiara
    De Cecco, Loris
    de Azambuja, Evandro
    Fumagalli, Debora
    Sotiriou, Christos
    Harbeck, Nadia
    Izquierdo, Miguel
    Nuciforo, Paolo
    Huober, Jens
    Cappelletti, Vera
    Cinieri, Saverio
    Piccart, Martine
    Daidone, Maria Grazia
    Pruneri, Giancarlo
    Colombo, Mario Paolo
    Tagliabue, Elda
    Verderio, Paolo
    Di Cosimo, Serena
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6307 - 6313
  • [45] Partial Tumor Irradiation in a Murine Model is Sufficient for Tumor Control via Activation of an Antitumor Immune Response
    Samstein, R.
    Markovsky, E.
    Li, H.
    Russell, J.
    Humm, J.
    Deasy, J. O.
    Powell, S. N.
    Haimovitz-Friedman, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E616 - E617
  • [46] Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
    Tiia J. Honkanen
    Milla E. K. Luukkainen
    Antti Tikkanen
    Peeter Karihtala
    Markus Mäkinen
    Juha P. Väyrynen
    Jussi P. Koivunen
    Breast Cancer Research and Treatment, 2022, 191 : 443 - 450
  • [47] Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
    Honkanen, Tiia J.
    Luukkainen, Milla E. K.
    Tikkanen, Antti
    Karihtala, Peeter
    Makinen, Markus
    Vayrynen, Juha P.
    Koivunen, Jussi P.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 443 - 450
  • [48] Combining chemotherapy, trastuzumab, and immune-checkpoint inhibitors in HER2-positive gastro-oesophageal cancer
    Smyth, Elizabeth C.
    Sundar, Raghav
    LANCET, 2023, 402 (10418): : 2168 - 2170
  • [49] Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition Slows Tumor Growth in a Novel Syngeneic Model of Neuroblastoma
    Barton, S. M.
    Okochi, S.
    Street, C.
    Banerjee, D.
    Kadenhe-Chiweshe, A.
    Yamashiro, D. J.
    Connolly, E. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E577 - E577
  • [50] Blocking soluble TNF to Improve potency of trastuzumab deruxtecan by increasing internalization and antitumor innate immune response in a resistant HER2-positive breast cancer model
    Bruni, Sofia
    Mauro, Florencia
    Naveiro, Sofia
    Cordo-Russo, Rosalia
    Dupont, Agustina
    Florencia, Mercogliano Maria
    Schillaci, Roxana
    CANCER RESEARCH, 2024, 84 (09)
12345